BIOLASE IncNASDAQ:BIOLNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.1440
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.1426/ 20
- Ask / Lots0.1488/ 7
- Open / Previous Close0.1520 / 0.1440
- Day Range
- 52 Week Range
- Volume546,367
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BIOL |
|---|---|---|
| 09:32 ET | 9348 | 0.1508 |
| 09:34 ET | 1050 | 0.1499 |
| 09:36 ET | 370 | 0.151 |
| 09:38 ET | 12577 | 0.1452 |
| 09:39 ET | 800 | 0.1507 |
| 09:41 ET | 2495 | 0.1477 |
| 09:43 ET | 332 | 0.1508 |
| 09:45 ET | 400 | 0.14785 |
| 09:48 ET | 12156 | 0.1459 |
| 09:52 ET | 1005 | 0.1474 |
| 09:54 ET | 200 | 0.149899 |
| 09:56 ET | 2242 | 0.1498 |
| 09:57 ET | 744 | 0.148 |
| 09:59 ET | 489 | 0.1498 |
| 10:01 ET | 350 | 0.1482 |
| 10:03 ET | 4250 | 0.149 |
| 10:06 ET | 10005 | 0.1451 |
| 10:08 ET | 29928 | 0.1411 |
| 10:10 ET | 800 | 0.1479 |
| 10:12 ET | 3248 | 0.1439 |
| 10:19 ET | 1925 | 0.1417 |
| 10:21 ET | 325 | 0.145759 |
| 10:28 ET | 2000 | 0.1417 |
| 10:30 ET | 1000 | 0.1445 |
| 10:32 ET | 300 | 0.1445 |
| 10:33 ET | 9500 | 0.1473 |
| 10:35 ET | 400 | 0.1418 |
| 10:42 ET | 138 | 0.142691 |
| 10:44 ET | 500 | 0.146599 |
| 10:46 ET | 400 | 0.1426 |
| 10:50 ET | 1000 | 0.1426 |
| 10:51 ET | 20000 | 0.1466 |
| 11:00 ET | 582 | 0.1444 |
| 11:02 ET | 2500 | 0.1444 |
| 11:04 ET | 13500 | 0.14501 |
| 11:06 ET | 280 | 0.1425 |
| 11:09 ET | 135 | 0.14543 |
| 11:11 ET | 100 | 0.143 |
| 11:15 ET | 100 | 0.1462 |
| 11:18 ET | 800 | 0.1462 |
| 11:20 ET | 410 | 0.1455 |
| 11:22 ET | 103 | 0.1463 |
| 11:36 ET | 100 | 0.145 |
| 11:38 ET | 900 | 0.145 |
| 11:40 ET | 400 | 0.1453 |
| 11:42 ET | 5000 | 0.1454 |
| 11:45 ET | 481 | 0.1453 |
| 11:47 ET | 10204 | 0.1454 |
| 11:54 ET | 5570 | 0.1451 |
| 11:58 ET | 800 | 0.1455 |
| 12:00 ET | 1349 | 0.145 |
| 12:02 ET | 135 | 0.144824 |
| 12:03 ET | 250 | 0.1449 |
| 12:07 ET | 4185 | 0.144 |
| 12:12 ET | 1261 | 0.1427 |
| 12:14 ET | 66863 | 0.1424 |
| 12:16 ET | 360 | 0.1426 |
| 12:20 ET | 2098 | 0.1427 |
| 12:21 ET | 1100 | 0.142439 |
| 12:23 ET | 500 | 0.1427 |
| 12:25 ET | 2525 | 0.1419 |
| 12:27 ET | 2499 | 0.1429 |
| 12:30 ET | 350 | 0.1446 |
| 12:34 ET | 2788 | 0.1411 |
| 12:36 ET | 27777 | 0.1438 |
| 12:39 ET | 2071 | 0.1429 |
| 12:41 ET | 13149 | 0.1446 |
| 12:43 ET | 404 | 0.141 |
| 12:45 ET | 500 | 0.143 |
| 12:50 ET | 500 | 0.142699 |
| 12:54 ET | 200 | 0.1411 |
| 01:01 ET | 19999 | 0.1442 |
| 01:03 ET | 2000 | 0.1442 |
| 01:08 ET | 724 | 0.1411 |
| 01:10 ET | 200 | 0.1449 |
| 01:12 ET | 280 | 0.1412 |
| 01:17 ET | 24933 | 0.1446 |
| 01:19 ET | 200 | 0.1447 |
| 01:21 ET | 489 | 0.142 |
| 01:24 ET | 2592 | 0.142 |
| 01:32 ET | 10000 | 0.142 |
| 01:35 ET | 434 | 0.142 |
| 01:39 ET | 4348 | 0.142 |
| 01:46 ET | 6338 | 0.1447 |
| 01:48 ET | 2000 | 0.1446 |
| 01:50 ET | 1209 | 0.1447 |
| 01:51 ET | 5000 | 0.1446 |
| 01:55 ET | 1135 | 0.1438 |
| 02:00 ET | 732 | 0.1446 |
| 02:02 ET | 500 | 0.1447 |
| 02:06 ET | 237 | 0.1426 |
| 02:11 ET | 360 | 0.144699 |
| 02:13 ET | 127 | 0.1428 |
| 02:22 ET | 2172 | 0.1427 |
| 02:24 ET | 184 | 0.1443 |
| 02:26 ET | 154 | 0.142845 |
| 02:42 ET | 100 | 0.1446 |
| 02:44 ET | 500 | 0.144 |
| 03:00 ET | 2500 | 0.1426 |
| 03:03 ET | 101 | 0.1434 |
| 03:16 ET | 396 | 0.1442 |
| 03:18 ET | 400 | 0.144 |
| 03:21 ET | 245 | 0.1443 |
| 03:25 ET | 1000 | 0.1447 |
| 03:27 ET | 4300 | 0.1441 |
| 03:30 ET | 800 | 0.144884 |
| 03:34 ET | 10603 | 0.1467 |
| 03:36 ET | 11739 | 0.1465 |
| 03:38 ET | 1100 | 0.14645 |
| 03:39 ET | 13862 | 0.1468 |
| 03:43 ET | 3302 | 0.1468 |
| 03:45 ET | 128 | 0.144 |
| 03:50 ET | 300 | 0.14545 |
| 03:54 ET | 246 | 0.1469 |
| 03:56 ET | 110 | 0.146199 |
| 03:57 ET | 500 | 0.1456 |
| 03:59 ET | 4923 | 0.144 |
Apr 1, 2024
DJ Biolase Is Maintained at Buy by Ascendiant Capital, from 5:50AM ET on Monday Apr 01, 2024 by Dow Jones
5:50AM ET on Monday Apr 01, 2024 by Dow Jones
Mar 26, 2024
Thinking about buying stock in Cardiff Oncology, BIOLASE, Akebia Therapeutics, Astera Labs, or Atossa Therapeutics?, from 9:31AM ET on Tuesday Mar 26, 2024 by Dow Jones
9:31AM ET on Tuesday Mar 26, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
BIOLASE Inc | 4.8M | 0.0x | --- |
Dynatronics Corp | 2.9M | -0.4x | --- |
IRIDEX Corp | 47.8M | -5.0x | --- |
Owlet Inc | 35.7M | -0.9x | --- |
ETAO International Co Ltd | 14.4M | 0.0x | --- |
LENSAR Inc | 37.1M | -2.4x | --- |
Company Information
BIOLASE, Inc. is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company's systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. It offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft-tissue) systems. The Company's all-tissue Waterlase dental laser systems consist of its flagship Waterlase iPlus, Waterlase Express, and Waterlase MDX. Its soft tissue diode laser systems consist of the Epic X, Epic Hygiene, Epic Q, and Epic 10 diode lasers that perform soft tissue, hygiene, cosmetic procedures, teeth whitening, and provide temporary pain relief. Epic X, and Epic 10 systems feature its 940 nanometer wavelength with patented pulse technology called ComfortPulse.
Contact Information
- Headquarters
- 27042 Towne Centre Drive, Suite 270FOOTHILL RANCH, CA, United States 92610
- Phone
- 949-361-1200
- Fax
- 949-273-6677
Executives
- Independent Chairman of the Board
- Jonathan Lord
- President, Chief Executive Officer
- John Beaver
- Chief Financial Officer
- Jennifer Bright
- Chief Operating Officer
- Steven Sandor
- Independent Director
- Kathleen O'Loughlin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.8M |
|---|---|
Revenue (TTM) | $49.2M |
Shares Outstanding | 33.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.72 |
EPS | $-37.97 |
Book Value | $0.57 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -36.48% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
